Pharmacology, Toxicology and Pharmaceutical Science
Anandamide
20%
Antiparkinson Agent
10%
Bioavailability
10%
Cannabinoid 1 Receptor
20%
Capsazepine
20%
Complication
10%
Dopamine
10%
Dynorphin
10%
Dyskinesia
50%
Levodopa
70%
Levodopa-Induced Dyskinesia
30%
Parkinson Disease
10%
Peroxisome Proliferator Activated Receptor
30%
Peroxisome Proliferator Activated Receptor Gamma
10%
Rat
40%
Receptor
10%
Receptor Subtype
10%
Rosiglitazone
20%
Transcription Factor
10%
URB597
20%
Vanilloid Receptor 1
10%
Neuroscience
Anandamide
20%
Cannabinoid 1 Receptor
20%
Capsazepine
20%
Catabolism
10%
Dopamine
10%
Dynorphin
10%
Dyskinesia
40%
Eicosanoid Receptor
10%
L-DOPA
100%
Parkinson's Disease
10%
Peroxisome Proliferator-Activated Receptor
30%
Peroxisome Proliferator-Activated Receptor Gamma
10%
Phosphorylation
10%
Receptor Subtype
10%
Rosiglitazone
20%
Striatum
10%
Transcription Factors
10%
URB597
20%
Vanilloid Receptor 1
10%